• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY UNKNOWN VALVE/SHUNT; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY UNKNOWN VALVE/SHUNT; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number UNKNOWN-V
Device Problems Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problems Wound Dehiscence (1154); Unspecified Infection (1930)
Event Date 09/07/2021
Event Type  Injury  
Event Description
Youngbo shim, kyung hyun kim, ji yeoun lee, seung-ki kim, ji hoon phi.The stability of multifocal ventriculoperitoneal shunts with y-connections.Child's nervous system 37 (2021).Doi: 10.1007/s00381-021-05349-8 abstract purpose multifocal ventriculoperitoneal shunts with y-connections (mvps with ys) are widely used in many centers when neuroendoscopic procedures on entrapped ventricles are not feasible; however, their use is not frequent.This study aimed to confirm the stability of an mvps with y and, for the first time, identify the factors that influence stability.Methods we studied 33 consecutive patients who underwent initial conversion tomvps with ys.The one-year overall shunt survival rate was calculated and compared with the historical outcome of single ventriculoperitoneal shunts (vpss).The factors influencing the one-year overall shunt survival rate were also investigated.The one-year survival rate for proximal catheters in each location was further investigated, and the rates were compared among locations.The factors affecting proximal catheter survival were determined.Results the one-year overall shunt survival rate of mvps with y was 70%, which was not much different from that of previously reported single vpss, including our institution.We found no significant factor influencing overall shunt survival, but when an additional catheter was inserted into the fourth ventricle, the survival rate was exceptionally low at 40% (p = 0.21).When we investigated the one-year survival rate of each proximal catheter, we found that the location of the proximal catheter showed a certain trend toward significance (p = 0.07), especially in the case of the fourth ventricle, which had the lowest survival rate at 57% and an odds ratio of 15.64 (p = 0.013) in multivariate analysis.However, when the catheter was sufficiently inserted parallel to the brain stem using navigation, the survival was relatively well maintained (1,995 to 2,547 days).Conclusions the stability of mvps with y was similar to that of single vpss.However, the malfunction rate of the proximal catheter inserted at the fourth ventricle in the y-connection was higher than that at other locations.The transcerebellar vertical approach or transtentorial approach parallel to the brain stem may decrease the malfunction rate.Reported events: - the most common cause of one-year overall failure leading to shunt revision was a newly ev in a different location (4/33).Regarding the cause of shunt failure, there were two proximal catheter malfunctions and one valve or distal catheter malfunction.Other causes were infection and wound dehiscence (one case for each), and there was no problem with the y-connector.The following valves were used 18 42856 strata ii valve, small; 12 42866 strata ii valve, regular; 2 42314 csf-flow control, contoured small, medium pressure; however, the article did not indicate which valves were associated with the failures.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN VALVE/SHUNT
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
5290 california ave
irvine CA 92617
Manufacturer (Section G)
MEDTRONIC NEUROSURGERY
5290 california ave
irvine CA 92617
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key12980539
MDR Text Key282096485
Report Number2021898-2021-00216
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
Reporter Country CodeKS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/10/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/10/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN-V
Device Catalogue NumberUNKNOWN-V
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/29/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-